295 related articles for article (PubMed ID: 20882098)
1. [Importance of exit site care as peritonitis prophylaxis: experience in our centre].
Conde Rivera O; Santos Nores J; Borrajo Prol M; Pérez Melón C
Nefrologia; 2010; 30(5):589-91. PubMed ID: 20882098
[No Abstract] [Full Text] [Related]
2. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
Chen SS; Sheth H; Piraino B; Bender F
Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
6. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP
Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139
[TBL] [Abstract][Full Text] [Related]
7. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
[TBL] [Abstract][Full Text] [Related]
8. [Candida-induced recurrent peritonitis after peritoneal catheter reinsertion].
Pérez Melón C; Conde Rivera O; Novoa Fernández E; Borrajo Prol M
Nefrologia; 2009; 29(2):183. PubMed ID: 19396335
[No Abstract] [Full Text] [Related]
9. Dialysis: The importance of peritoneal catheter exit-site care.
Piraino B
Nat Rev Nephrol; 2010 May; 6(5):259-60. PubMed ID: 20424630
[No Abstract] [Full Text] [Related]
10. Prevention of peritoneal dialysis-related infections.
Nessim SJ
Semin Nephrol; 2011 Mar; 31(2):199-212. PubMed ID: 21439433
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
12. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.
Aykut S; Caner C; Ozkan G; Ali C; Tugba A; Zeynep G; Taner C
Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
Sachar M; Shah A
Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
[TBL] [Abstract][Full Text] [Related]
15. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
Davenport A;
J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients.
Piraino B; Bernardini J; Florio T; Fried L
Perit Dial Int; 2003; 23(5):456-9. PubMed ID: 14604197
[TBL] [Abstract][Full Text] [Related]
17. Insights on peritoneal dialysis-related infections.
Piraino B
Contrib Nephrol; 2009; 163():161-168. PubMed ID: 19494610
[TBL] [Abstract][Full Text] [Related]
18. Prevention of peritonitis in peritoneal dialysis.
Segal JH; Messana JM
Semin Dial; 2013; 26(4):494-502. PubMed ID: 23859192
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
[TBL] [Abstract][Full Text] [Related]
20. Exit site infections: systematic microbiologic and quality control are needed.
Freitas C; Rodrigues A; Carvalho MJ; Cabrita A
Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]